Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2016 084 033.2 |
96 | EP file number | EAKZ | 16 81 5375.7 |
86 | WO file number | WAKZ | PCT/US2016/039245 |
97 | EP publication number | EPN | 3313818 |
87 | WO publication number | WPN | 2016210262 |
54 | Designation/title | TI | VERFAHREN ZUR BEHANDLUNG VON KAPOSI-SARKOM ODER KSVH-INDUZIERTEM LYMPHOM UNTER VERWENDUNG IMMUNMODULATORISCHER VERBINDUNGEN UND VERWENDUNGEN VON BIOMARKERN |
51 | IPC main class | ICM (ICMV) | C07D 209/48 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/404 (2006.01), A61K 45/06 (2006.01), C07D 471/04 (2006.01), C07D 473/34 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Jun 24, 2016 |
96 | EP application date | EAT | Jun 24, 2016 |
86 | WO application date | WAT | Jun 24, 2016 |
43 | Date of first publication | OT | Dec 29, 2016 |
| Date of publication of grant | PET | Nov 8, 2023 |
71/73 | Applicant/owner | INH | Celgene Corporation, Princeton, NJ, US; The U.S.A. as represented by the Secretary, Department of Health and Human Services, Bethesda, MD, US |
72 | Inventor | IN | YARCHOAN, Robert, Bethesda, MD 20817, US; Zeldis, Jerome, Princeton, NJ 08540, US; POLIZZOTTO, Mark, Paddington, New South Wales 2021, AU; DAVIS, David, Bethesda, MD 20817, US; SERETI, Irini, Washington, DC 20004, US; ULDRICK, Thomas, Washington, DC 20005, US; WHITBY, Denise, Frederick, MD 21701, US; KHETANI, Vikram, Short Hills, NJ 07078, US |
| Address for service | | VALIPAT, 1050 Brussels, BE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201562185265 P Jun 26, 2015
|
| Due date | FT FG | Jun 30, 2026 Annual fee for the 11th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003313818A1 Searchable text:
EP000003313818A1 Original document:
EP000003313818B1 Searchable text:
EP000003313818B1 Original document:
WO002016210262 Searchable text:
WO002016210262 |
43 | Date of first publication | EVT | Dec 29, 2016 |
| Date of the first transfer into DPMAregister | EREGT | May 2, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | May 7, 2025 (Show all update days)(Hide all update days)- May 7, 2025
- Due date: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 08.11.2023: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 08.11.2023: deleted
- Oct 18, 2024
- Address for service: changed
- Procedures: Procedure relating to EP application, Grant has become final, 09.08.2024: changed
- Sep 26, 2024
- Procedures: Procedure relating to EP application, Grant has become final, 09.08.2024: new
- Jul 25, 2024
- St.36: changed (technical change)
- May 30, 2024; May 14, 2024; May 2, 2024; Apr 18, 2024; Mar 14, 2024; Dec 6, 2023; Nov 16, 2023; Oct 20, 2023; Oct 19, 2023; Jul 6, 2023; Sep 20, 2018
- Historical data not available for this/these date(s)
- May 2, 2018
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 13, 2024 |
| Issue number | HN | 16 |
| Year | PJ | 2024 |
| Publication date | VT | Apr 18, 2024 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Celgene Corporation, Princeton, NJ, US; The U.S.A. as represented by the Secretary, Department of Health and Human Services, Bethesda, MD, US |
71/73 | Previous applicant/owner | INHF | Celgene Corporation, Summit, NJ, US, The U.S.A. as represented by the Secretary, Department of Health and Human Services, Bethesda, MD, US |
| Date of update of the procedure | REGT | Apr 18, 2024 |